Home
|
Inbox
|
Search
|
Speaker
Christopher E. Brightling
BSc(Hons), MBBS, PhD
University of Leicester;University of Leicester, Maurice Shock Medical School
Session(s)
- Efficacy and Safety of Tralokinumab in Two Phase III Trials of Severe, Uncontrolled Asthma...
Sunday, May 20 2:15 PM - 4:15 PM - Effect of Tralokinumab Upon Eosinophilic Airway Inflammation in Participants with Moderate...
Monday, May 21 10:45 AM - 11:00 AM - Do Raised Serum Ige and Eosinophils Have an Affect on Quality of Life and Patient Related ...
Tuesday, May 22 11:15 AM - 1:00 PM - Urine Biomarkers of COPD Exacerbation; A Feasibility Study [Board No. P1328]
Tuesday, May 22 11:15 AM - 1:00 PM
|
Home
|
Inbox
|
Search
|